(Q36299974)

13 August 2017

1 reference

title

Cardiovascular disease and toxicities related to HIV infection and its therapies (English)

1 reference

13 August 2017

main subject

cardiovascular disease

1 reference

Karolina M Zareba

1

1 reference

13 August 2017

Tracie L Miller

series ordinal

2

1 reference

13 August 2017

Steven E Lipshultz

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Expert Opinion on Drug Safety

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

1017-1025

1 reference

Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Tuberculosis epidemics driven by HIV: is prevention better than cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Role of human immunodeficiency virus in primary pulmonary hypertension--case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Pericardial effusion in AIDS. Incidence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Cardiac manifestations of acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Cardiac tamponade in patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Association between exercise and HIV disease progression in a cohort of homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Effect of resistance training on self-reported physical functioning in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Cardiovascular Complications in Patients with HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1017

10.1517/14740338.4.6.1017

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference